1. Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor α and Yes Kinase
   Yuki Ohkawa et al, 2015, Journal of Biological Chemistry CrossRef
2. Identification of potent Yes1 kinase inhibitors using a library screening approach
   Paresma R. Patel et al, 2013, Bioorganic & Medicinal Chemistry Letters CrossRef
3. A Succinate Ether Derivative of Tocotrienol Enhances Dickkopf-1 Gene Expression through Epigenetic Alterations in Malignant Mesothelioma Cells
   Ayami Sato et al, 2018, Pharmacology CrossRef
4. Pseudogenes in gastric cancer pathogenesis: a review article
   Modjtaba Emadi-Baygi et al, 2017, Briefings in Functional Genomics CrossRef
5. c-Yes enhances tumor migration and invasion via PI3K/AKT pathway in epithelial ovarian cancer
   Yunfeng Jin et al, 2016, Experimental and Molecular Pathology CrossRef
6. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1
   Weiqi Tan, 2015, World Journal of Gastroenterology CrossRef
7. The Src family tyrosine kinases src and yes have differential effects on inflammation-induced apoptosis in human pulmonary microvascular endothelial cells
   Leif D. Nelin et al, 2016, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
8. miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1
   Zheng Fang et al, 2017, Molecular Cancer CrossRef
9. Cyclin-dependent kinase 1-mediated phosphorylation of YES links mitotic arrest and apoptosis during antitubulin chemotherapy
   Zhan Wang et al, 2018, Cellular Signalling CrossRef
10. Etv2 transcriptionally regulates Yes1 and promotes cell proliferation during embryogenesis
    Bhairab N. Singh et al, 2019, Scientific Reports CrossRef
11. Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade
    Paola Indovina et al, 2020, Cancers CrossRef
12. A renaissance for YES in cancer
    Marjorie Lapouge et al, 2023, Oncogene CrossRef
13. Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
    Arnaud Boyer et al, 2018, European Respiratory Review CrossRef
14. Impact of Kidney Function on the Blood Proteome and on Protein Cardiovascular Risk Biomarkers in Patients With Stable Coronary Heart Disease
    Joseph Yang et al, 2020, Journal of the American Heart Association CrossRef
15. MicroRNA‑133a inhibits the proliferation of non‑small cell lung cancer by targeting YES1
    Yuyao Shen et al, 2019, Oncology Letters CrossRef
16. Spontaneous Mesotheliomas in F344/N Rats Are Characterized by Dysregulation of Cellular Growth and Immune Function Pathways
    Pamela E. Blackshear et al, 2014, Toxicologic Pathology CrossRef
17. YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib
    Irati Garmendia et al, 2019, American Journal of Respiratory and Critical Care Medicine CrossRef
18. MicroRNA‐140 inhibit prostate cancer cell invasion and migration by targeting YES proto‐oncogene 1
    Shijia Zhao et al, 2020, Journal of Cellular Biochemistry CrossRef
19. Gene Expression of Mesothelioma in Vinylidene Chloride–exposed F344/N Rats Reveal Immune Dysfunction, Tissue Damage, and Inflammation Pathways
    Pamela E. Blackshear et al, 2015, Toxicologic Pathology CrossRef
20. YES1: A Novel Therapeutic Target and Biomarker in Cancer
    Irati Garmendia et al, 2022, Molecular Cancer Therapeutics CrossRef
21. A Redox-Inactive Derivative of Tocotrienol Suppresses Tumor Growth of Mesothelioma Cells in a Xenograft Model
    Ayami Sato et al, 2019, Biological and Pharmaceutical Bulletin CrossRef
22. Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines
    Valentina Monica et al, 2016, Oncotarget CrossRef
23. Emerging Roles of YES1 in Cancer: The Putative Target in Drug Resistance
    Eunjin Kook et al, 2024, International Journal of Molecular Sciences CrossRef